Sort
23,748 grants matching “melanoma”
Identification of the molecular mechanism of miR-211 and its target genes in melanocytes and pigmented melanoma senescence and apoptosis
$254,475Ranjan Joseph Perera · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2016 · CA
Functional landscape of Eph receptor mutations in melanoma
$254,475Elena B Pasquale · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2014 · CA
Systems biology of glutamine utilization in melanoma
$254,475Jeffrey W Smith · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2014 · CA
RNF125 controls melanoma response to B-RAF inhibitor and immune checkpoint therapy
$254,475Hyungsoo Kim · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2015 · CA
UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis
$254,434Shiyong Wu · Ohio University Athens · R01 · FY2012 · CA
DEVELOPMENTAL RESEARCH PROGRAM
$254,432Elizabeth A Grimm · University Of Tx Md Anderson Can Ctr · P50 · FY2007 · CA
Molecular, Cellular, and Tissue Characterization Unit
$254,428Sandro Santagata · Harvard Medical School · U2C · FY2023 · CA
Targeting the ERK Pathway in KRAS-and BRAF-Driven Lung Cancers
$254,404Neal Rosen · Sloan-Kettering Inst Can Research · P01 · FY2012 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$254,385University Of Pittsburgh At Pittsburgh · U10 · FY2002 · CA
Molecular genetic dissection of epidermodysplasia verruciformis
$254,250Emmanuelle Jouanguy · Rockefeller University · R21 · FY2014 · AI
Elucidating the mechanism by which ADAR1 prevents autoimmunity against self RNA
$254,250Charles M. Rice · Rockefeller University · R21 · FY2023 · AI
Genome-wide detection of UV DNA damage by single molecule real time sequencing
$254,250Aneel K. Aggarwal · Icahn School Of Medicine At Mount Sinai · R21 · FY2015 · ES
Characterization of early events in bulge McSCs and their progeny during melanoma
$254,250Mayumi Ito · New York University School Of Medicine · R21 · FY2014 · ES
Role of Tumor in Therapeutic Response and Resistance
$254,210Lynda Chin · University Of Tx Md Anderson Can Ctr · U54 · FY2014 · CA
Endothelial cell injury by cytolytic lymphocytes
$254,180Virginia Commonwealth University · R01 · FY2004 · HL
Pilot Projects and Trans-Network Activities Core
$254,153Meenhard Herlyn · Wistar Institute · U54 · FY2017 · CA
CD70 Mediated Costimulation of T Cell Responses
$254,118Timothy N Bullock · University Of Virginia · R56 · FY2008 · CA
AP-1 AND CHEMOPREVENTION OF UV INDUCED NONMELANOMA SKIN CANCER
$254,104University Of Arizona · P01 · FY2000 · CA
CORE--MOLECULAR GENETICS
$254,104University Of Arizona · P01 · FY2000 · CA
EVALUATION OF CHEMOPREVENTIVE AGENTS USING A TRANSGENIC MOUSE MELANOMA MODEL
$254,104University Of Arizona · P01 · FY2000 · CA
PHASE IIB STUDIES FOR PREVENTION OF NONMELANOMA SKIN CANCER
$254,104University Of Arizona · P01 · FY2000 · CA
PHARMACOLOGY AND PHASE II STUDIES OF TOPICAL AGENTS FOR SKIN CANCER PREVENTION
$254,104University Of Arizona · P01 · FY2000 · CA
Control and Impacts of Diseases in Zebrafish Research Facilities
$254,058Michael Lawrence Kent · Oregon State University · R24 · FY2016 · OD
FUSOGENIC MEMBRANE GLYCOPROTEINS FOR CANCER GENE THERAPY
$253,980Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2003 · CA
FUSOGENIC MEMBRANE GLYCOPROTEINS FOR CANCER GENE THERAPY
$253,980Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2002 · CA